GlassScriptPhysician profile
Eugene L Go
NPI 1730166125
$14,621.62
in general payments reported to CMS, 2019-2025
46 companies · $2,456 in 2025
The $2,456 reported for 2025 was more than what 79% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,064 · 2020: $1,558 · 2021: $2,010 · 2022: $3,027 · 2023: $1,750 · 2024: $1,757 · 2025: $2,456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,846 · Education: $118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,845.53 |
| Education | $117.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,633.87 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,765.63 | 2019-2025 | Breztri, Airsupra, Fasenra |
| Actelion Pharmaceuticals US, INC. | $1,317.25 | 2019-2025 | Uptravi, Opsumit |
| Philips North America LLC | $1,219.30 | 2019-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Genzyme Corporation | $1,032.64 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $977.09 | 2019-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $789.68 | 2019-2025 | Ofev, Stiolto Respimat, Jascayd |
| Mylan Specialty L.P. | $495.39 | 2019-2024 | Yupelri |
| Electromed, INC. | $488.23 | 2019-2025 | Smartvest |
| Novartis Pharmaceuticals Corporation | $320.24 | 2019-2025 | |
| Insmed, INC. | $306.14 | 2019-2025 | Arikayce |
| Verona Pharma, INC. | $272.20 | 2025 | Ohtuvayre |
| Bayer Healthcare Pharmaceuticals INC. | $264.61 | 2019-2022 | |
| Harmony Biosciences LLC | $254.16 | 2020-2022 | |
| Sunovion Pharmaceuticals INC. | $226.94 | 2019-2020 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $193.21 | 2020-2022 | |
| Genentech USA, INC. | $183.05 | 2019-2025 | Xolair |
| Gilead Sciences, INC. | $182.50 | 2021-2022 | |
| Amgen INC. | $164.55 | 2022-2025 | Tezspire |
| Jazz Pharmaceuticals INC. | $152.02 | 2019-2025 | Xywav |
| Merck Sharp & Dohme LLC | $148.42 | 2019-2024 | Zerbaxa, Winrevair |
| Mallinckrodt Hospital Products INC. | $147.46 | 2021-2025 | Acthar |
| Takeda Pharmaceuticals U.S.A., INC. | $132.22 | 2021-2022 | |
| Inogen, INC. | $113.71 | 2021-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Grifols USA, LLC | $113.46 | 2019-2021 | |
| Advanced Respiratory, INC | $77.39 | 2019-2021 | |
| Shire North American Group INC | $73.15 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $57.04 | 2019-2021 | |
| Allergan, INC. | $54.24 | 2019-2020 | |
| Covis Pharma Gmbh | $50.67 | 2022 | |
| Circassia INC. | $43.73 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $40.61 | 2022 | |
| Pfizer INC. | $39.20 | 2019-2024 | |
| Viatris Specialty LLC | $36.89 | 2025 | Yupelri |
| Baxter Healthcare | $34.49 | 2023-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Fisher & Paykel Healthcare INC | $34.26 | 2021-2025 | Fisher & Paykel Healthcare |
| Vifor Pharma, INC. | $31.56 | 2024 | Zemaira |
| Vapotherm INC | $23.50 | 2023 | Vapotherm |
| Atricure, INC. | $21.38 | 2024 | |
| Abbvie INC. | $18.97 | 2021 | |
| Pulmonx Corporation | $18.06 | 2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Tactile Systems Technology INC | $16.57 | 2024 | Flexitouch Plus, Entre Plus |
| Hikma Pharmaceuticals USA | $14.43 | 2024 | Ryaltris |
| Lilly USA, LLC | $14.30 | 2025 | Zepbound |
| E.R. Squibb & Sons, L.L.C. | $13.68 | 2022 | |
| Phadia US INC. | $13.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Go listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.